top of page


"Tom's expert knowledge and superb technical writing skills were instrumental in preparing our company's first IND filing.  In addition, his dedication to detail and high quality work, together with a remarkable ability to contextualize our non-clinical safety data for the FDA, enabled us to adhere to aggressive timelines. Reflecting the impeccable quality of Tom’s work, the Agency asked no questions about the non-clinical sections of our IND filing."


-  Vera Hoffman,  CEO, Reveal Pharmaceuticals Inc

bottom of page